Not an emergency service. In an emergency, contact local emergency services now.
All news

Multiple myeloma · Dual-target CAR-T

Australia Shanghai

An Australian doctor’s own search for myeloma treatment led to Shanghai

Amanda Harvey understood medicine as a doctor and as someone living with aggressive myeloma. By 2025, repeated relapses had made the search for another option increasingly personal.

The condition
Aggressive myeloma with repeated relapses
The medical resource
BCMA/GPRC5D dual-target CAR-T
The journey
Cell therapy and recovery in Shanghai

The experience behind the BBC interview

BBC World Service’s Asia Specific interviewed Harvey about travelling to Shanghai after several rounds of treatment for multiple myeloma. Her story formed part of a discussion about China’s growing role in cancer treatment and access to CAR-T.

A seven-week journey with complications and follow-up

In her own account for Myeloma Australia, Harvey described receiving dual-target CAR-T in 2025, mild cytokine release syndrome and readmission for a respiratory infection. Before leaving, a bone marrow test found no myeloma cells. Back in Australia, she continued immune support and reported improved wellbeing, while acknowledging uncertainty about how long control would last.

The access story has already changed

Myeloma Australia added that Carvykti had subsequently become available through Australia’s PBS after four prior treatment lines. Her earlier travel decision therefore should not be presented as proof that Australians have no domestic CAR-T option today.

China Care perspective

What this case helps us understand

Her account connects specialist cellular therapy in Shanghai with continuing care in Australia. It also includes the practical work around treatment: recovery, a support person and follow-up at home. This makes the story useful as a picture of an international care journey. The subsequent Australian access update adds context to the options that existed when she decided to travel.

Sources & further reading

Original reporting belongs to the publishers below. This article is an independently written account based on those sources, with editorial interpretation identified above.

  1. BBC World Service · Media interview · EnglishWhy cancer patients are flying to China for treatment — Asia Specific (opens in a new tab)

    Official BBC episode and published episode description; not a full transcript review

  2. Myeloma Australia · Patient’s first-person account · EnglishTravelling to China for CAR T-cell therapy — Amanda Harvey (opens in a new tab)

    Treatment details, complications, follow-up and publisher’s subsequent access update

China Care did not provide the care described. This story does not imply a relationship with the patient or hospital, or that China Care can arrange the same treatment. Individual outcomes do not predict other patients’ results. This is editorial information, not medical advice.

Published by China Care on 29 October 2026. Patient experiences and treatment access reflect the dates of the cited reporting.